3 February 2021

Conditions

Proliferative plantar fibroma – a case study

3 February 2021

Biologics Spondyloarthritis

Can synovial biopsies predict RA treatment response?

3 February 2021

Spondyloarthritis

Simple screening tool to predict infection risk in RA

27 January 2021

O&G Scleroderma Spondyloarthritis

MyRA enters next phase of RA community support

27 January 2021

Conditions

Clinical clues and treatments for Raynaud’s

27 January 2021

Conditions

How patients want their healthcare team to communicate

18 December 2020

Biologics Spondyloarthritis

Gilead will not pursue FDA approval of filgonitib for RA

15 December 2020

Analgesics Conditions Spondyloarthritis

Vagus nerve stimulation for RA symptom control

15 December 2020

Conditions Psychology Sex

Love (and sex) in the time of COVID-19

15 December 2020

Conditions COVID-19 Telehealth

How rheumatology changed in 2020

15 December 2020

Cognitive Therapies Osteoarthritis Spondyloarthritis

News bites: New treatment for scleroderma?

14 December 2020

Conditions Technology Telehealth

A tech-tonic shift in healthcare

14 December 2020

Conditions Diet Obesity Polymyalgia Rheumatica

Non-drug options to avoid gout

3 December 2020

Analgesics Conditions Spondyloarthritis

Battle of the monotherapies: etanercept vs methotrexate

3 December 2020

Analgesics Conditions Lupus

Ixekizumab PBS-subsidised for AS

3 December 2020

Ankylosing Spondylitis Biologics Corticosteroids Juvenile Arthritis Medications

‘Absolutely invaluable’, ‘Big-Brother like’: ARA initiative sparks controversy